Walker Crips Group plc (WCW.L)
GBp 12.75
(0.0%)
GBp 12.75
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.23 Million | 3.51 Million | 4.14 Million | 1.48 Million | 3.55 Million | -565 Thousand |
| Net Income | 368 Thousand | 418 Thousand | 55 Thousand | -258 Thousand | 718 Thousand | 333 Thousand |
| Depreciation & Amortization | 1.93 Million | 2.07 Million | 2.03 Million | 2.17 Million | 2.06 Million | 1.14 Million |
| Deferred income taxes | - | -4.36 Million | -1.75 Million | -4.43 Million | -4.21 Million | -1.85 Million |
| Stock-based compensation | 43 Thousand | 60 Thousand | 57 Thousand | 94 Thousand | 239 Thousand | 209 Thousand |
| Change in working capital | -1.12 Million | -156 Thousand | 2.37 Million | 8000.00 | 113 Thousand | 1.64 Million |
| Other non-cash items | 5.05 Million | 5.47 Million | 1.37 Million | 3.9 Million | 4.63 Million | -2.04 Million |
| Investing Cash Flow | 424 Thousand | -538 Thousand | -449 Thousand | -46 Thousand | -242 Thousand | -214 Thousand |
| Investments in PPE | -218 Thousand | -333 Thousand | -212 Thousand | -24 Thousand | -321 Thousand | -382 Thousand |
| Acquisitions | - | - | 105 Thousand | -100 Thousand | -22 Thousand | -711 Thousand |
| Investment purchases | - | -205 Thousand | -342 Thousand | -78 Thousand | -101 Thousand | -78 Thousand |
| Sales/Maturities of investments | 642 Thousand | - | 105 Thousand | 78 Thousand | 101 Thousand | 789 Thousand |
| Other Investing Activities | 984 Thousand | -293 Thousand | -105 Thousand | 78 Thousand | 101 Thousand | 168 Thousand |
| Financing Cash Flow | -935 Thousand | -949 Thousand | -1.43 Million | -1.19 Million | -1.49 Million | -799 Thousand |
| Debt repayment | -623 Thousand | -246 Thousand | -959 Thousand | -999 Thousand | -944 Thousand | - |
| Dividends payments | -213 Thousand | -617 Thousand | -383 Thousand | -64 Thousand | -396 Thousand | -796 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -122 Thousand | -86 Thousand | -93 Thousand | -134 Thousand | -157 Thousand | -3000.00 |
| Accounts receivables | 4.39 Million | 13.66 Million | -915 Thousand | -24.57 Million | 11.05 Million | 1.64 Million |
| Accounts payables | -5.52 Million | -13.81 Million | 3.29 Million | 24.58 Million | -10.89 Million | -3.8 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5.52 Million | - | - | - | -44 Thousand | 3.8 Million |
| Cash at beginning of period | 13.13 Million | 11.11 Million | 8.85 Million | 8.6 Million | 6.91 Million | 8.36 Million |
| Cash at end of period | 13.86 Million | 13.13 Million | 11.11 Million | 8.85 Million | 8.6 Million | 6.78 Million |
| Capital Expenditure | -218 Thousand | -333 Thousand | -212 Thousand | -24 Thousand | -321 Thousand | -382 Thousand |
| Effect of forex changes on cash | - | - | - | - | -127 Thousand | - |
| Net cash flow / Change in cash | 725 Thousand | 2.02 Million | 2.25 Million | 246 Thousand | 1.69 Million | -1.57 Million |
| Free Cash Flow | 1.01 Million | 3.17 Million | 3.93 Million | 1.46 Million | 3.23 Million | -947 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 167 Thousand | 368 Thousand | 201 Thousand | 301 Thousand | 418 Thousand | 117 Thousand |
| Depreciation & Amortization | 1.04 Million | 1.93 Million | 886 Thousand | 1.1 Million | 2.07 Million | 968 Thousand |
| Deferred income taxes | - | - | - | -865 Thousand | -4.36 Million | - |
| Stock-based compensation | 43 Thousand | 43 Thousand | - | 60 Thousand | 60 Thousand | - |
| Change in working capital | -11.07 Million | -1.12 Million | -372 Thousand | 1.4 Million | -156 Thousand | -1.55 Million |
| Other non-cash items | 10.06 Million | 5.05 Million | 2.13 Million | 1.46 Million | 5.47 Million | 4.01 Million |
| Investing Cash Flow | 312 Thousand | 424 Thousand | 373 Thousand | -278 Thousand | -538 Thousand | -260 Thousand |
| Investments in PPE | -82 Thousand | -218 Thousand | -34 Thousand | -294 Thousand | -333 Thousand | -39 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | 16 Thousand | -205 Thousand | -221 Thousand |
| Sales/Maturities of investments | 235 Thousand | 642 Thousand | 407 Thousand | - | - | - |
| Other Investing Activities | 394 Thousand | 984 Thousand | 590 Thousand | -92 Thousand | -293 Thousand | -201 Thousand |
| Financing Cash Flow | -750 Thousand | -935 Thousand | -166 Thousand | -671 Thousand | -949 Thousand | -278 Thousand |
| Debt repayment | - | -623 Thousand | -118 Thousand | - | -246 Thousand | -239 Thousand |
| Dividends payments | -213 Thousand | -213 Thousand | - | -617 Thousand | -617 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -537 Thousand | -122 Thousand | -90 Thousand | -50 Thousand | -86 Thousand | -45 Thousand |
| Accounts receivables | -11.07 Million | 4.39 Million | 15.47 Million | -6.07 Million | 13.66 Million | 19.73 Million |
| Accounts payables | 10.32 Million | -5.52 Million | -15.84 Million | 7.47 Million | -13.81 Million | -21.29 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 14.05 Million | 13.13 Million | 13.13 Million | 10.62 Million | 11.11 Million | 11.11 Million |
| Cash at end of period | 13.86 Million | 13.86 Million | 14.05 Million | 13.13 Million | 13.13 Million | 10.62 Million |
| Capital Expenditure | -82 Thousand | -218 Thousand | -34 Thousand | -294 Thousand | -333 Thousand | -39 Thousand |
| Effect of forex changes on cash | - | - | 13.13 Million | -13.13 Million | - | 11.11 Million |
| Net cash flow / Change in cash | -188 Thousand | 725 Thousand | 913 Thousand | 2.51 Million | 2.02 Million | -490 Thousand |
| Free Cash Flow | 168 Thousand | 1.01 Million | 672 Thousand | 3.17 Million | 3.17 Million | 9000.00 |
1157
GMLA
8028
0909
CFTLF
IVBT